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Abstract 
Purpose: To prepare and evaluate in vitro mucoadhesive esomeprazole magnesium microspheres for 
the treatment of Zollinger Ellison syndrome.  
Methods: The microspheres were prepared by spray drying technique using locust bean and xanthan 
gums as polymers. Esomeprazole magnesium was entrapped in the microspheres at various 
polymer/cross-linking ratios. Glutaraldehyde was used to cross-link the gums. The microspheres were 
evaluated for their micromeritic properties and in vitro release. as well as by Fourier transform infrared 
(FTIR), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM). 
Results: The microspheres were discrete, spherical, and showed good drug entrapment efficiency 
(60.5 - 92.3 %). FTIR and DSC results indicate that the drug was compatible with the polymers used. 
Amongst all the formulations, F6 (drug:locust bean gum:xanthan gum, 1:2:2) showed the most suitable 
sustained release properties with 99.8 % of drug released at the end of 12 h.  
Conclusion: Microspheres prepared using locust bean and xanthan gums can be used as a sustained 
release delivery system for esomeprazole magnesium. 
 
Keywords: Spray drying, Microspheres, Esomeprazole magnesium, Sustained release 
 
Tropical Journal  of Pharmaceutical Research is ind exed by Science Citation Index (SciSearch), Scopus,  
International Pharmaceutical Abstract, Chemical Abs tracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Report s/Science Edition, Directory of Open Access Journal s 




Zollinger-Ellison syndrome is a condition in which 
the patient suffers from ulcers in the upper 
digestive tract (that do not respond to 
medications), excessive gastric acid secretion 
and diarrhea. The increased acid secretion 
results in inflammation and ulcers in the stomach 
and lower food pipe, and diarrhea [1]. 
 
Esomeprazole is chemically bis(5-methoxy-2-
[(S)-[(4-methoxy-3,5-dimethyl-2 pyridinyl) methyl] 
sulfinyl]-1-H-benzimidazole-1-yl), a compound 
that inhibits gastric acid secretion. Esomeprazole 
is inactive at neutral pH, but at pH < 5 rearranges 
to two charged cationic forms (a sulphenic acid 
and a sulphenamide configurations) that react 
covalently with SH groups of the H+K+ATPase 
enzyme and inactivate it irreversibly, especially 
when two molecules of omeprazole react with 
one molecule of the enzyme. Its bioavailability is 
89% and has a plasma elimination half life of 1.5 
h [2].  
 
Various natural polymers such as locust bean 
and xanthan gums, chitosan and gelatin have 
been used to develop drug delivery systems for 
entrapping and delivering drugs orally [3]. 
Biodegradable microspheres can be prepared 
from certain synthetic as well as natural 
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polymers. Biodegradable carrier matrices can be 
designed to deliver the therapeutic agent for 
periods ranging from a few days to a few years 
[4]. The use of natural polymers such as agar, 
guar gum, chitosan, gelatin, carboxy methyl 
cellulose, xanthan gum, karaya gum, sodium 
alginate and locust bean gum to delivery drugs 
promises to be an active area of research due to 
their natural origin, easy availability, cost 
effectiveness, ecofriendliness, possibility of 
chemical modifications and are potentially 
biodegradable [5]. 
 
Locust bean gum powder is obtained from the 
Carob (Ceratonia siliqua) tree. It consists of high 
molecular weight (approximately 50,000 - 
3,000,000) polysaccharides composed of 
galactomannans; the mannose: galactose ratio is 
about 4:1. It is safe and acceptable for use in 
food and does not show any hazards to health 
[6]. 
 
Xanthan gum is a polysaccharide produced by 
fermentation of glucose or sucrose, mainly corn 
sugar, by Xanthomonas campestris bacterium to 
produce a clear and sticky liquid which is dried to 
obtain gum. It helps in stabilizing emulsion by 
increasing viscosity, suspending insoluble solids 
in various preparations, retarding drug release, 
and hence useful in sustaining drug release [7,8]. 
The main aim of the present study is to develop 
and evaluate esomeprazole magnesium 
microspheres using the natural polymers, locust 







Esomeprazole magnesium trihydrate and 
Eudragit®L100 were gifts from Dr. Reddy’s 
Laboratories Ltd, Hyderabad, India. Locust bean 
gum and xanthan gums were obtained from 
Sigma Aldrich, USA. Glutaraldehyde was 
purchased from Loba Chemie, India. All other 
materials used were of analytical grade. 
 
Preparation of microspheres 
 
Mucoadhesive microspheres were prepared by 
spray drying technique. An aqueous solution 
containing different combinations/ratios of the 
polymers (Table 1) were prepared by dissolving 
locust bean and xanthan gums in distilled de-
ionized water. The drug (1 g), previously 
dissolved in 100 ml of absolute methanol, was 
added to the polymer solution and sonicated 
using Ultra sonicator (1204 AU-Vibracell, USA) to 
obtain a homogeneous mixture. A crosslinking 
agent, glutaraldehyde (0 –  0.30 ml), was added 
to the homogenized solution and spray dried by 
spraying through the nozzle of a spray-dryer 
(JISL, LSD- 48 mini spray dryer, India) at input 
temperature of 115  -117 °C, output temperature 
of 80 – 85 °C at 2 % feed rate and vacuum 
pressure of 35 psi (2.4 kg/cm2). The resulting 
microspheres were ollected from the spray dryer 
and kept in a desiccator containing silica gel 
pending further tests [9].  
 
Enteric coating of microspheres 
 
An enteric coating solution (4.0 % w/v) containing 
Eudragit®L100 was dissolved in a mixture of 
ethanol and dicholoromethane (1:1). Di-butyl 
phthalate (15 %w/w based on the polymer) was 
added as plasticizer stirred with a magnetic 
stirrer for sufficient period of time (1 h). The 
previously prepared microspheres was added to 
the solution, mixed well, and the mixture spray-
dried by spraying through the nozzle of a spray-
dryer (Lab Spray drier, JISL, Mumbai, India). The 
process conditions were set as follows: Inlet 
temperature 60 – 65 °C, outlet temperature 50-
55°C at 2% feed rate and vacuum pressure of 35 
psi (2.4 kg/cm2). The coated microspheres were 
retrieved from the spray dryer. 
 
Determination of drug entrapment efficiency 
and yield 
 
The drug entrapment efficiency (DEE) and yield 
of coated microspheres were computed by Eqs 1 
and 2, respectively. 
   DEE = (Pc / Tc) × 100 ……..…………….. (1) 
where Pc is actual drug content and Tc is the 
theoretical drug content. units were analyzed in 
triplicate. 
   Yield (%) = (W1/W2) x 100………………….. (2) 
where  W1 is the weight of microspheres and W2 
is the total weight of drug and polymer used in 
formulating the microspheres.  
 
Particle size analysis 
 
The particle size of the microspheres was 
determined by optical microscopy method. 
Approximately 100 microspheres were counted 
using a calibrated optical microscope (Labomed 




The swelling ability of the uncoated microspheres 
in physiological media was determined by 
immersing an accurately weighed amount (500 
mg) of microspheres in a little excess of 100 ml 
of phosphate buffer (pH 6.8) and kept for 24 h. 
Eq 3 was to compute the degree of swelling. 
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  Ssw = (Ws - Wo/Wo) x 100 …………………… (3) 
 
where Ssw = percent swelling of microspheres, 
Wo = initial weight of microspheres, Ws = weight 
of microsphere after swelling [10]. 
 
Differential scanning calorimetry (DSC) 
 
DSC study was carried out to detect possible 
polymorphic transition during the preparation 
process. DSC measurements were performed on 
a differential scanning calorimeter (DSC, DuPont 
9900, USA) with a thermal analyzer. The 
samples were heated in an atmosphere of 
nitrogen at a constant heating rate of 10 oC/min 
in the range of 20 – 220 oC.  
 
Fourier transform infrared spectroscopy (FT-
IR) 
 
The samples of pure drug and formulation F6 
were dispersed in 200 mg of KBr powder and 
compressed into pellets at a pressure of 6000 
kg/cm2 and analyzed. Spectral measurements 
were obtained by powder diffuse reflectance on a 
FT-infrared spectrophotometer (Shimadzu, FT-IR 
8400S, Japan). 
 
Scanning electron microscopy (SEM) 
 
Scanning electron microscopy (Joel- LV-5600, 
USA) was applied to obtain photomicrographs 
which were used to identify and confirm the 
surface topography of the microspheres.  
 
In vitro release studies 
 
The release profiles of the formulations were 
determined using USP dissolution apparatus 
XXIV-Type II (TDT-08T, Electro Lab, Mumbai). 
The microspheres were enclosed in a muslin 
cloth which was then tied to the lowest part of the 
paddle. The paddle was then rotated (100 rpm) 
immersed in pH 1.2 HCl buffer and for 2 h, and 
immediately transferred to a phosphate buffer 
(pH 6.8) medium and tested for 10 h at 37 ± 0.5 
°C. Aliquots of 5 ml were withdrawn  hourly over 
a period of 12 h. Drug content was determined 
spectrophotometrically (UV 1601 A Shimadzu, 
Japan) at 302.13 nm. The studies were carried 
out in triplicate, and the release data obtained 
were fitted into various release models, namely, 
zero order (Eq 4), first order (Eq 5), Higuchi (Eq 
6) and Korsmeyer-Peppas (Eq 7). 
Qt = Kot…………………… (4) 
ln Qt = ln Qo – K1t …….. (5) 
Qt = Kh t
½ ………………… (6) 
 Mt/Mo = Kp t
n ……………. (7) 
 
Where K is constant, Qt is the amount of drug 
released at time, 0 or t, Mt is also the amount of 
drug diffused at tome, 0 or t tTo determine 
release mechanism, the parameters n and k in 





Data were assessed for statistical significance by 
Student t-test at 95 % level of confidence level 




Drug entrapment efficiency and % yield 
 
With increase in the concentration of crosslinking 
agent, DEE increased, as shown in Table 1. DEE 
ranged from 60 – 92 %. Low DEE was observed 
for uncrosslinked microspheres (F1 - F3) The 
difference was significant (p < 0.05). Microsphere 
yield ranged from 30 – 65 %. 
 
Particle size analysis 
 
The size of particles varied with the 
concentration of polymer used and the feed rate. 




Swelling results are shown in Table 1, and they 
indicate that as polymer concentration rose, the 
degree of swelling also increased (p < 0.05).  
 
Differential scanning calorimetry (DSC) 
 
The DSC thermograms obtained are displayed in 
Figure 1. It shows that the decomposition 
temperature of drug was 177.3 °C and 
formulation F6 was 171.2 °C. 
 
Fourier Transform Infrared spectroscopy (FT-
IR) 
 
The FT-IR spectra of the pure drug microsphere 
formulation (F6) are shown in Figure 2. The 
broad peak at 3217.01 cm-1 in the spectra of the 
pure drug corresponds to C=N group. The peak 
at 108.32 cm-1 corresponds to C=S boding. The 
peaks at 1613.2 cm-1 and 1581.2 cm-1 indicate 
the presence of carbonyl group. The drug and 
polymers employed were found to be compatible 
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size (µm)   
Swelling   
(%)  
F1 1:2:0 0.0 30.3±1.0 60.5±2.5 5.32±1.23 200±6 
F2 1:2:1 0.0 32.5±1.2 72.5±3.2 5.68±1.56 226±7 
F3 1:2:2 0.0 45.1±1.5 81.2±3.5 8.23±2.11 264±8 
F4 1:2:0 0.15 39.2±1.1 71.6±4.6 4.45±1.56 163±5 
F5 1:2:1 0.15 49.6±1.7 83.2±5.8 4.61±1.42 172±5 
F6 1:2:2 0.15 52.5±2.4 86.5±5.6 5.05±1.53 185±4 
F7 1:2:0 0.30 42.5±1.7 72.5±4.8 2.13±0.92 116±4 
F8 1:2:1 0.30 56.3±2.3 83.9±6.1 3.66±1.12 128±6 
F9 1:2:2 0.30 65.1±2.6 92.3±3.5 4.25±1.37 150±5 














Figure 1: DSC thermograms of (A) pure 
esomeprazole magnesium and (B) drug-loaded 
microspheres (F6)  
 
Fourier Transform Infrared spectroscopy (FT-
IR) 
 
The FT-IR spectra of the pure drug microsphere 
formulation (F6) are shown in Figure 2. The 
broad peak at 3217.01 cm-1 in the spectra of the 
pure drug corresponds to C=N group. The peak 
at 108.32 cm-1 corresponds to C=S boding. The 
peaks at 1613.2 cm-1 and 1581.2 cm-1 indicate 
the presence of carbonyl group. The drug and 
polymers employed were found to be compatible 
as similar peaks were observed with minor 
differences.  
 
In vitro drug release  
 
Figure 4 depicts the drug release profile of the 
various microsphere formulations.  Increase in 
the content of polymer decreased drug release. 
Uncrosslinked microspheres showed significantly 
faster release than crosslinked formulations (p < 
0.05). Based on the correlation coefficient (R2) 
values, drug release was zero order and drug 
release mechanism showed a good fit to 
Korsmeyer Peppas model (Table 2). The 
diffusion exponent ‘n’ was > 0.85 indicating that 
the formulations showed super case II transport 
kinetics, which mean that more than one 
mechanism may be involved in the drug release, 
i.e., drug release by diffusion, erosion and 
polymer chain relaxation. 
 
 
Figure 2:  FT-IR spectra of (A) pure esomeprazole 
magnesium and (B) microsphere formulation (F6)  
Scanning electron microscopy 
 
 
The microspheres appeared to be spherical and 




Figure 3:  Scanning electron micrographs of 
microsphere formulation F6; 5000 x magnification 
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Table 2: Kinetic release data of mucoadhesive microspheres 
 
Formulation 
code Zero order First order Higuchi 
Korsmeyer-
Peppas n 
F1 0.8732 0.7125 0.6523 0.9145 0.9345 
F2 0.8784 0.7632 0.6589 0.9567 1.1102 
F3 0.8123 0.7741 0.7123 0.9894 0.9864 
F4 0.8720 0.7489 0.6589 0.9103 0.9956 
F5 0.8111 0.7852 0.6656 0.9456 1.1506 
F6 0.8123 0.7413 0.5789 0.8956 1.1023 
F7 0.8746 0.7631 0.6952 0.9666 0.9923 
F8 0.8560 0.7789 0.6854 0.9742 0.9658 
F9 0.8314 0.8120 0.7100 0.9856 1.1450 
 
In vitro drug release  
 
Figure 4 depicts the drug release profile of the 
various microsphere formulations.  Increase in 
the content of polymer decreased drug release. 
Uncrosslinked microspheres showed significantly 
faster release than crosslinked formulations (p < 
0.05). Based on the correlation coefficient (R2) 
values, drug release was zero order and drug 
release mechanism showed a good fit to 
Korsmeyer Peppas model (Table 2). The 
diffusion exponent ‘n’ was > 0.85 indicating that 
the formulations showed super case II transport 
kinetics, which mean that more than one 
mechanism may be involved in the drug release, 
i.e., drug release by diffusion, erosion and 





Figure 4:  In vitro release profiles of esomeprazole 
magnesium microsphere formulations F1 (◊), F2 (■), 
F3 (∆), F4 (●), F5 (▲), F6 (○), F7 (+), F8 (♦) and F9 




Drug entrapment efficiency (DEE) depended on 
the extent of crosslinking between cross linking 
agent and the gums. This can be attributed to the 
fact that higher extent of cross linking resulted in 
formation of a more rigid network structure which 
prevented the leaching out of drug during 
preparation of microspheres. 
 
Increase in polymer concentration increased 
microsphere size.  This may be due to increased 
viscosity leading to formation of bigger droplets. 
On the other hand, the decrease in particle size 
with increasing in the extent of crosslinking 
suggests that during crosslinking, the polymeric 
network transforms to a rigid network which is 
associated with shrinkage [12].  
 
Formulations of uncrosslinked microspheres 
showed burst release which can be explained by 
rapid swelling followed by erosion unlike 
crosslinked microspheres. Swellability data 
revealed that the amount of polymer and 
crosslinker played an important role in solvent 
transfer. As the concentration of polymer 
increased, erosion reduces and hence swelling 
becomes greater. However, swelling decreased 
with increased crosslinking density, as much 
tighter networks are formed at higher 
concentration of crosslinking agent. At lower 
crosslink density, the network is loose with a 
greater hydrodynamic free volume, such that the 
chains can accommodate more of the solvent 
molecules, resulting in higher swelling. The 
swelling results are supported by the in vitro drug 
release data obtained [13] and similar findings 
elsewhere [9]. 
 
Non-aggregated microspheres with spherical 
shape were observed. Absence of crystalline 
structures on the surface of the microspheres 
indicates that esomeprazole magnesium was 
well dispersed inside the carrier.  
 
The lack of disappearance of or significant shift 
in the peak position of drug in the FT-IR spectra 
of the drug and their corresponding DSC 
303 
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thermograms is an indication that the drug and 
polymers used for the study are compatible. 
 
As the polymer content of the of the 
microspheres increased, the extent of drug 
release decreased. For the first two hours, the 
release was negligible (< 5 %) for all the 
formulations. This is due to the enteric nature of 
Eudragit L 100 which dissolves only in pH > 6.0. 
The uncrosslinked microspheres (F1, F2 and F3) 
showed complete release by the end of 8 h. 
Crosslinked microspheres with 0.15 % 
glutaraldehyde (F4, F5 and F6) showed 
cumulative drug release (CDR) > 85 % at the 
end of 12 h. Crosslinked microspheres 
containing 0.30 % glutaraldehyde shows (F7, F8 
& F9 ) showed  incomplete release at the end of 
12 h. The above release patterns correlate with 
swelling.  
 
Super Case II transport is reported to be 
exhibited when diffusion and relaxation rates are 
comparable. In general, relaxational contribution 
was probably higher for formulations with higher 
Korsemeyer-Peppas ‘n’ value coupled with 
swelling and erosion which can be attributed to 
the hydrophilic gums. Hence, it can be suggested 
that the sustained release was achieved due to 




Crosslinked esomeprazole magnesium 
microspheres prepared with locust bean and 
xanthan gums by spray drying technique showed 
sustained release properties. However, further 
studies are required to evaluate the 
microspheres in vivo and to determine their 
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